ArticleOncotarget2015

Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.

Wei-Ling Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.